---
figid: PMC3109860__Fig4_REVDent
figlink: /pmc/articles/PMC3109860/figure/f4-0110133/
number: Figure 4
caption: Multiple CHK1 inhibitors promote compensatory activation of the RAS-SRC /
  MEK1/2 / ERK1/2 pathway. The survival pathway can be inhibited at various points
  along its course that reveals the true toxicity of CHK1 inhibitor exposure. Killing
  is mediated via the intrinsic / mitochondrial cell death pathway.
pmcid: PMC3109860
papertitle: CHK1 Inhibitors in Combination Chemotherapy.
reftext: Paul Dent, et al. Mol Interv. 2011 Apr;11(2):133-140.
pmc_ranked_result_index: '80033'
pathway_score: 0.9647431
filename: Fig4_REVDent.jpg
figtitle: CHK1 Inhibitors in Combination Chemotherapy
year: '2011'
organisms: Homo sapiens
ndex: 637a4918-dea5-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3109860__Fig4_REVDent.html
  '@type': Dataset
  description: Multiple CHK1 inhibitors promote compensatory activation of the RAS-SRC
    / MEK1/2 / ERK1/2 pathway. The survival pathway can be inhibited at various points
    along its course that reveals the true toxicity of CHK1 inhibitor exposure. Killing
    is mediated via the intrinsic / mitochondrial cell death pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MCL1
  - MAP2K1
  - PARP1
  - APAF1
  - ATM
  - BCL2L1
  - MAPK1
  - BAX
  - BAK1
  - CHEK1
  - MAPK3
  - ATR
  - SRC
  - HRAS
  - MAP2K2
  - RAF1
  - KRAS
  - NRAS
  - R115777
  - Tipifarnib
  - AZD0530
  - AZD6244
  - AZD2281
  - AZD7762
  - PF-477736
  - SCH900776
  - Cancer
genes:
- word: MCL-1
  symbol: Mcl-1
  source: hgnc_alias_symbol
  hgnc_symbol: MCL1
  entrez: '4170'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PARP1
  symbol: PARP1
  source: hgnc_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: Apaf-1
  symbol: APAF-1
  source: hgnc_alias_symbol
  hgnc_symbol: APAF1
  entrez: '317'
- word: ATM
  symbol: ATM
  source: hgnc_symbol
  hgnc_symbol: ATM
  entrez: '472'
- word: BCL-XL
  symbol: bcl-xL
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: BAX
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: BAK
  symbol: BAK
  source: hgnc_alias_symbol
  hgnc_symbol: BAK1
  entrez: '578'
- word: CHK1-
  symbol: CHK1
  source: hgnc_alias_symbol
  hgnc_symbol: CHEK1
  entrez: '1111'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: CHK1-ATM/ATR
  symbol: ATR
  source: hgnc_symbol
  hgnc_symbol: ATR
  entrez: '545'
- word: SRC
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAF-1
  symbol: Raf-1
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
chemicals:
- word: R115777
  source: MESH
  identifier: C402769
- word: Tipifarnib
  source: MESH
  identifier: C402769
- word: AZD0530
  source: MESH
  identifier: C515233
- word: AZD6244
  source: MESH
  identifier: C517975
- word: AZD2281
  source: MESH
  identifier: C531550
- word: AZD7762
  source: MESH
  identifier: C532363
- word: PF-477736
  source: MESH
  identifier: C532366
- word: SCH900776
  source: MESH
  identifier: C559815
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
